Yiliang Li

发表

Acetyl-CoA carboxylase (ACC) as a therapeutic target for metabolic syndrome and recent developments in ACC1/2 inhibitors

Yong Qin, Leyuan Chen, Yuqing Duan, 2019, Expert opinion on investigational drugs.

DUOXA1-mediated ROS production promotes cisplatin resistance by activating ATR-Chk1 pathway in ovarian cancer.

Wei Zheng, Weiqun Peng, Yan Kai, 2018, Cancer letters.

Hypoxia-Driven Immunosuppressive Metabolites in the Tumor Microenvironment: New Approaches for Combinational Immunotherapy

S. Patel, J. Roszik, Yong Qin, 2018, Front. Immunol..

Ursolic Acid Derivative UA232 Promotes Tumor Cell Apoptosis by Inducing Endoplasmic Reticulum Stress and Lysosomal Dysfunction

Hongying Wu, Huiqiang Wei, Hongxin Ning, 2022, International journal of biological sciences.

Novel PHD2/HDACs hybrid inhibitors protect against cisplatin-induced acute kidney injury.

Huiqiang Wei, Hongxin Ning, Yiliang Li, 2022, European journal of medicinal chemistry.

Design, synthesis and biological evaluation of novel 4-anilinoquinazoline derivatives as hypoxia-selective EGFR and VEGFR-2 dual inhibitors.

Yong Qin, Yuqing Duan, Huiqiang Wei, 2019, European journal of medicinal chemistry.

Design and Synthesis of Vandetanib Derivatives Containing Nitroimidazole Groups as Tyrosine Kinase Inhibitors in Normoxia and Hypoxia

Saijun Fan, H. Shang, Huiqiang Wei, 2016, Molecules.

Recent progress in small-molecule inhibitors for critical therapeutic targets of necroptosis.

Leyuan Chen, Huiqiang Wei, Changfen Bi, 2021, Future medicinal chemistry.

Design and synthesis of benzodiazepines as brain penetrating PARP-1 inhibitors

Tiemin Sun, Yiliang Li, Yating Cui, 2022, Journal of enzyme inhibition and medicinal chemistry.

Identification of potent SENP1 inhibitors that inactivate SENP1/JAK2/STAT signaling pathway and overcome platinum drug resistance in ovarian cancer

Wei Zheng, Wenge Zhu, Yunxiao Meng, 2021, Clinical and translational medicine.

Phosphate group functionalized magnetic metal–organic framework nanocomposite for highly efficient removal of U(VI) from aqueous solution

Langxing Chen, Ye Yuan, Hongxin Ning, 2021, Scientific Reports.

Discovery of Natural Ursane-type SENP1 Inhibitors and the Platinum Resistance Reversal Activity Against Human Ovarian Cancer Cells: A Structure-Activity Relationship Study.

Huiqiang Wei, Hongxin Ning, Yiliang Li, 2022, Journal of natural products.

Discovery and radiosensitization research of ursolic acid derivatives as SENP1 inhibitors.

Huiqiang Wei, Hongxin Ning, Yiliang Li, 2021, European journal of medicinal chemistry.

One-Pot Synthesis of 3-Functionalized 4-Hydroxycoumarin under Catalyst-Free Conditions

Yang Gao, Guoning Zhang, Juxian Wang, 2018, Molecules.

An Improved Synthesis of the Triethylene Glycol-Substituted 4-(N-Methyl-N-Boc-Amino)Styrylpyridine

Yuqing Duan, Huiqiang Wei, Hongxin Ning, 2020, ACS omega.

miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer

Weiqun Peng, Yan Kai, A. Tzatsos, 2018, Oncogene.

Discovery and characterization of potent And‐1 inhibitors for cancer treatment

Ruili Huang, M. Xia, Wei Zheng, 2021, Clinical and translational medicine.

Protective effects of zingerone derivate on ionizing radiation-induced intestinal injury

Saijun Fan, Yuqing Duan, Yiliang Li, 2019, Journal of radiation research.

SENP1-mediated deSUMOylation of JAK2 regulates its kinase activity and platinum drug resistance

Wei Zheng, A. Cheung, Huadong Pei, 2021, Cell Death & Disease.

Caloric restriction alleviates radiation injuries in a sex‐dependent fashion

Saijun Fan, Bin Wang, Jia-li Dong, 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Structure-based design, synthesis, and evaluation of inhibitors with high selectivity for PARP-1 over PARP-2.

Tiemin Sun, Yiliang Li, Yating Cui, 2021, European journal of medicinal chemistry.

SUMO-specific protease 1 inhibitors–A literature and patent overview

Leyuan Chen, Yiliang Li, Wenbin Hou, 2022, Expert opinion on therapeutic patents.

Discovery of novel triazole compounds as selective IL-1β releasement inhibitors.

Lei Zhu, C. Ye, Leyuan Chen, 2021, Bioorganic & medicinal chemistry letters.

Targeted inhibition of acidic nucleoplasmic DNA-binding protein 1 enhances radiosensitivity of non-small cell lung cancer.

Hongying Wu, Daiying Zuo, Yingliang Wu, 2022, Cancer letters.

Ursolic acid derivative UA232 evokes apoptosis of lung cancer cells induced by endoplasmic reticulum stress

Na Luo, Hongying Wu, Yuqing Duan, 2020, Pharmaceutical biology.

Protective effect of total flavonoids of Engelhardia roxburghiana Wall. leaves against radiation-induced intestinal injury in mice and its mechanism.

Hongxin Ning, Yiliang Li, Wenfeng Gou, 2023, Journal of ethnopharmacology.

PET imaging of new target CDK19 in prostate cancer.

Ting Huang, Saijun Fan, Dong Dai, 2023, European journal of nuclear medicine and molecular imaging.

Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation

S. Jiao, Daiying Zuo, Yiliang Li, 2022, Frontiers in Pharmacology.